BSECompany Update3d ago · 24 Jul 2026, 09:50 pm

The board of directors in its meeting held on July 24 ,2026 has considered and approved the redesignation of Mr. Hiren Shah as the Chairman and Managing director of the company.

Integrated Proteins Ltd · 519606

✦ AI SummaryMgmt Change

The board of directors of Integrated Proteins Ltd has approved the re-designation of Mr. Hiren Shah as the Chairman and Managing Director of the company, subject to shareholder approval. The company has also fixed the date for an Extra-Ordinary General Meeting (EGM) to consider the re-designation and other matters.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Integrated Proteins Ltd - 519606 - Announcement under Regulation 30 (LODR)-Change in Directorate

Attachments (1)

📄

63890208-b89f-469f-937a-7ca8cd1b7d47.pdf

pdf

Download →
View document text
INTEGRATED PROTEINS LIMITED Manek Centre,Of(cid:976)ice No 218,P N Marg,Jamnagar – 361008, Gujarat,India Phone:9428817400 Email ID: integrated.pl2024@gmail.com Website: www.integratedproteins.com CIN: L62013GJ1992PLC018426 Date: 24.07.2026 Department of Corporate Services BSE Limited 25th Floor, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400001 Scrip Code: 519606 Sub.: Outcome of Board Meeting held on July 24, 2026 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 Dear Sir/ Madam, Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its meeting held today i.e. Friday, July 24, 2026 at the Registered Office of the Company situated at Office no. 218, Manek Centre, Pandit Nehru Marg, Patel colony, Jamnagar-361008, which commenced at 20:30 HRS(IST) and concluded at 21:00 HRS (IST) has inter alia considered and approved the following: 1. Re-Designation of Mr. Hiren Dhirajlal Shah (DIN: 09842161), from Additional Executive Director to the Chairman and Managing Director of the Company.- Board of Directors accorded their consent to Re-designate Mr. Hiren Shah (DIN: 09842161), the Additional Executive Director of the Company as " Chairman and Managing Director" of the Company subject to the approval of members in general meeting of the company, to hold such office for a period of 5 (Five) commencing from July 24 ,2026 and ending on July 23, 2031 pursuant to provisions of Sections 196, 197 and 203 read with Schedule V of the Companies Act, 2013 ("the Act") read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 and other applicable provisions, if any, of the Companies Act, 2013 (including any statutory modification or re-enactment thereof, for the time being in force) and subject to the Memorandum and Articles of Association of the company. Further, Mr. Hiren Shah is not debarred from holding the office of Director by virtue of any order of the Securities and Exchange Board of India (SEBI) or any other such authority. The particulars required as per SEBI Master Circular No HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026, on Disclosure of material events / information by listed entities under Regulations 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure A. INTEGRATED PROTEINS LIMITED Manek Centre,Of(cid:976)ice No 218,P N Marg,Jamnagar – 361008, Gujarat,India Phone:9428817400 Email ID: integrated.pl2024@gmail.com Website: www.integratedproteins.com CIN: L62013GJ1992PLC018426 2. Notice of Extra- Ordinary General Meeting- The Board of Directors has fixed the day, date, time and place for the Extra Ordinary General Meeting (“EGM”) of the Company. The Board approved convening of an Extra-Ordinary General Meeting (EOGM) of the Company for the financial year 2026-27 of the members of the Company on Thursday, 20th August , 2026, through Video Conferencing (VC) / Other Audio Visual Means (OAVM), and approved the Notice of the EGM along with the Explanatory Statement pursuant to Section 102 of the Companies Act, 2013. The Board has appointed Mrs. Ankita Tejas Shah, Practicing Company Secretary(Membership No: A43289, COP No: 16359 ) as a Scrutinizer of the Company for conducting the e-voting process in Extra- Ordinary General Meeting of the Company. The e-voting period commences on Monday, 17th August, 2026 at 9.00 A.M. and ends on Wednesday , 19th August, 2026 at 05.00 P.M. During this period members of the Company holding shares either in Physical form or in dematerialized form as of Thursday, August 13 ,2026 (cut-off date for E-voting) may cast their vote through remote e- voting. Yours Faithfully, For , Integrated Proteins Limited Shivangi Paliwal Company Secretary M. No: A80556 INTEGRATED PROTEINS LIMITED Manek Centre,Of(cid:976)ice No 218,P N Marg,Jamnagar – 361008, Gujarat,India Phone:9428817400 Email ID: integrated.pl2024@gmail.com Website: www.integratedproteins.com CIN: L62013GJ1992PLC018426 Annexure – A Details as required in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026. S. No. Particulars Details 1. Name Hiren Dhirajlal Shah 2. Designation Chairman and Managing director 3. Din 09842161 4. Reason for change viz. appointment, Re-Designation of Mr. Hiren Shah(DIN: resignation, removal, death or otherwise 09842161), the Additional Executive Director, as the Chairman and Managing Director of the Company. 5. Date of appointment / cessation (as 24.07.2026(subject to the approval of applicable) shareholders) 6. Brief profile (in case of appointment) Mr. Hiren holds a Bachelor of Computer Applications (BCA) degree and a Bachelor of Laws (LL.B.) degree from Saurashtra University. He possesses substantial experience in the areas of finance, accounting, business administration and corporate management. Over the years, he has been actively involved in financial planning, accounting and regulatory compliance matters and has acquired valuable expertise in financial management and strategic decision-making. 7. Disclosure of relationship between None directors (in case of appointment of a director )